UNSPSC 51333108: Etazolate hydrochloride

This classification denotes an anxiolytic with the molecular formula C14H19N5O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7YO3254Y6B, chemically known as 1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester but more generally known as etazolate hydrochloride, which bears US NIH Compound Identifier 3277. Most nations, for tariff and trade purposes, schedule etazolate hydrochloride under HS 29339990 and SITC 51577.

As of Q4 2014, ETAZOLATE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Etazolate hydrochloride bears US NLM identifiers UMLS ID C0917853 and NCI Concept Code C72768. SMILES: CCN1C2C(CN1)C(C(CN2)C(=O)OCC)NN=C(C)C.CL.

UNSPSC 51333108 Etazolate hydrochloride is a Commodity code for a pharmaceutical active ingredient, but the recent state and local procurement activity posted under this code does not align with the nominal commodity scope. The single recent opportunity on file — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits Naloxone and Safe Drug Deactivation Systems, not etazolate hydrochloride. The mismatch suggests either a coding error in the state or local procurement system or a broader taxonomy issue; the actual goods being procured are finished pharmaceuticals and medical devices, not raw chemical compounds.

The Seminole County opportunity does provide a concrete signal of state and local demand in the opioid-response space. The county is seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under an IFB with a response deadline of July 26, 2023 (note: the posting date of June 30, 2026, appears inconsistent with the 2023 deadline in the source). The contract carries a two-year initial term with an optional one-year renewal, fixed-fee pricing, potential FEMA funding, and standard requirements including drug-free workplace certification, E-Verify compliance, and specified insurance coverages. Given the code's mismatch with actual solicitation content, pursuit should be cautious; verify with the source or issuing body whether this code has been applied correctly or whether a different Commodity code better reflects the intended market.